Pharmaceuticals

Global Colorectal Cancer Drugs Market Outlook, Opportunities And Strategies

December 13, 2021 by The Business Research Company

Learn about the global colorectal cancer drugs market through The Business Research Company, which provides information on colorectal cancer drugs market size, colorectal cancer drugs market drivers and restraints, colorectal cancer drugs market players, the COVID-19 impact on the colorectal cancer drugs market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global colorectal cancer drugs market is expected to decline from $6.23 billion in 2020 to $6.09 billion in 2021 at a compound annual growth rate (CAGR) of -2.2%. The slow decline is mainly due to the outbreak of COVID-19 that has led to decrease in demand for immunocompromised treatments. The colorectal cancer drugs market is expected to reach $6.85 billion in 2025 at a CAGR of 3%.

Factors such as low-fibre diet, obesity, consumption of alcohol and tobacco amongst others. are expected to drive innovation in colorectal cancer drugs manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Colorectal Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smph

The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting large intestine and the rectum. They are also named, colon tumour or rectal cancer depending upon where they begin.

Global colorectal cancer drugs market segments include:

By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators

By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Others

By Class: Immunotherapy, Chemotherapy, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Targeted therapies have already begun to extend the lifespan of metastatic Colorectal cancer patients compared with chemotherapy-only therapy. Target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells. Opdivo and Keytruda are examples of targeted therapies.

TBRC’s colorectal cancer drugs market report covers:

Major Market Players: Merck & Co. Inc., Roche, Sanofi, Amgen, and Pfizer, Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides colorectal cancer drugs market overviews, analyses and forecasts market size, share, colorectal cancer drugs market players, colorectal cancer drugs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s colorectal cancer drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Cancer Biologics Global Market Report 2021

Cancer Clinical Decision Tools Global Market Report 2021

Cancer Vaccines Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model